Autopsy report · NCT03992326

Adoptive Transfer Of Autologous Tumor-Infiltrating Lymphocytes in Solid Tumors

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Internal competitive study that is open”

The sponsor’s own words in the registry.

Life of this trial

Registered 2 months before it started.
Ran for about 1 year 6 months before it stopped.
6 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1
Sponsor: Centre Hospitalier Universitaire Vaudois
Sponsor type: University, hospital or other
Conditions: Solid Tumor, Adult
Interventions: TIL; Cyclophosphamide; Fludarabine; Interleukin-2; Radiotherapy
Participants: 6
Sites: 1
Countries: Switzerland

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.